A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in non-dialysis subjects with anemia associated with chronic kidney disease to evaluate the safety and efficacy of study drug compared to standard of care.

August 16, 2018
Principal Investigator: Kausik Umanath, MD
Chronic Kidney Disease, Anemia
Accepting Participants